Dalya Rosner

Dalya Rosner is an accomplished scientist with extensive experience in immunology and drug development. Currently serving as a Staff Scientist and previously as a Senior Scientist at Alector since 2021, Dalya leads research efforts for Alzheimer's disease programs, achieving significant milestones like IND clearance. Previously, at TrueBinding from 2020 to 2021, Dalya focused on translating discovery biology into clinical programs, resulting in multiple patents and IND submissions. At IGM Biosciences, Dalya was the lead scientist on immuno-oncology targets and managed various research projects. Educational credentials include a Ph.D. in Immunology from Cambridge University, an M.Sc. in Immunology from the University of Colorado, and a BA in Biology from the University of Pennsylvania.